GLENMARK LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 812.3 INR | -1.87% |
|
-2.13% | +23.63% |
| 04-25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 | |
| 04-25 | Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Glenmark Life Sciences Limited
Price target over the last 5 years
History of analyst recommendation changes
19a2cb982f69e46a8c15.0y5LWiyoD0j_G-ak-r4CaTtsO6CwL2rh8mXUH1yerdw.t0QtL0OfRTuGVJzHtNFlXUo1aPTSWTmErS7nVDv0yqilGzECVcpIEMlY3g~b146b6ae60087f4df7d1a5a1a01dcf69
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
812.3
INR
Average target price
905.8
INR
Spread / Average Target
+11.50%
High Price Target
993
INR
Spread / Highest target
+22.25%
Low Price Target
790
INR
Spread / Lowest Target
-2.75%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GLS Stock
- Consensus Glenmark Life Sciences Limited
